Ovid Therapeutics (DE:1OT)
NASDAQ:1OT
Earnings Data
Report Date
Aug 18, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.1Last Year’s EPS
-0.05Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
DE:1OT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DE:1OT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2026 | €2.34 | €2.32 | -0.85% |
Mar 18, 2026 | €1.64 | €1.71 | +4.27% |
Nov 12, 2025 | €1.13 | €1.16 | +2.65% |
Aug 13, 2025 | €0.44 | €0.43 | -2.27% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ovid Therapeutics (DE:1OT) report earnings?
Ovid Therapeutics (DE:1OT) is schdueled to report earning on Aug 18, 2026, TBA (Confirmed).
What is Ovid Therapeutics (DE:1OT) earnings time?
Ovid Therapeutics (DE:1OT) earnings time is at Aug 18, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Ovid Therapeutics stock?
The P/E ratio of Ovid Therapeutics is N/A.
What is DE:1OT EPS forecast?
DE:1OT EPS forecast for the fiscal quarter 2026 (Q2) is -0.1.